Apollo Hospitals Enterprise Limited (IN:APOLLOHOSP)
:APOLLOHOSP
Want to see IN:APOLLOHOSP full AI Analyst Report?
Top Page
Apollo Hospitals Enterprise Limited
(APOLLOHOSP)
Select Model
Select Model
Rating:66Neutral
Price Target:
₹7,397.00
▲(4.46% Upside)
Action:Reiterated
Date:11/01/25
Apollo Hospitals' strong financial performance is the primary driver of its stock score, supported by robust revenue growth and efficient cash flow management. However, technical indicators suggest potential bearish trends, and the high P/E ratio indicates possible overvaluation, which tempers the overall score.
Positive Factors
Revenue Growth
Sustained revenue growth (~13.7% reported) signals durable demand for Apollo’s services across hospitals, diagnostics and pharmacies. This supports capacity utilization, reinvestment in high-return services and long-term earnings expansion as the company scales its integrated care model.
Negative Factors
Rising Capital Expenditure Pressure
Higher capex reduces free cash flow and can constrain discretionary investments or dividend flexibility if sustained. Ongoing heavy investments require clear return paths; otherwise they may compress margins or force additional financing, weakening long-term cash returns to shareholders.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained revenue growth (~13.7% reported) signals durable demand for Apollo’s services across hospitals, diagnostics and pharmacies. This supports capacity utilization, reinvestment in high-return services and long-term earnings expansion as the company scales its integrated care model.
Read all positive factors
Apollo Hospitals Enterprise Limited (APOLLOHOSP) vs. iShares MSCI India ETF (INDA)
Market Cap
₹1.16T
Dividend Yield0.27%
Average Volume (3M)4.82K
Price to Earnings (P/E)50.4
Beta (1Y)0.87
Revenue Growth14.52%
EPS Growth37.54%
CountryIN
Employees83,147
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)116.28
Shares Outstanding143,784,650
10 Day Avg. Volume6,428
30 Day Avg. Volume4,819
Financial Highlights & Ratios
PEG Ratio1.60
Price to Book (P/B)11.25
Price to Sales (P/S)4.23
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)166.76
Revenue Forecast (FY)₹303.32B
Apollo Hospitals Enterprise Limited Business Overview & Revenue Model
Company Description
Apollo Hospitals Enterprise Limited, together with its subsidiaries, provides healthcare services in India and internationally. The company's healthcare facilities comprise primary, secondary, and tertiary care facilities. Its tertiary care hospit...
How the Company Makes Money
Apollo Hospitals generates revenue primarily through its hospital operations, which include inpatient and outpatient services. The company charges fees for various medical services, surgeries, and treatments provided in its hospitals. Additionally...
Apollo Hospitals Enterprise Limited Financial Statement Overview
Summary
Income Statement
85
Very Positive
Balance Sheet
78
Positive
Cash Flow
80
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 232.65B | 252.28B | 217.94B | 190.59B | 166.13B | 146.63B |
| Gross Profit | 76.71B | 82.77B | 73.50B | 63.98B | 56.68B | 51.31B |
| EBITDA | 31.67B | 37.69B | 27.98B | 22.11B | 19.11B | 20.45B |
| Net Income | 16.72B | 19.42B | 14.46B | 8.99B | 8.19B | 10.56B |
Balance Sheet | ||||||
| Total Assets | 219.50B | 221.97B | 206.57B | 167.53B | 144.28B | 131.92B |
| Cash, Cash Equivalents and Short-Term Investments | 31.44B | 21.33B | 27.93B | 11.89B | 7.26B | 10.48B |
| Total Debt | 79.87B | 84.93B | 78.64B | 53.33B | 43.32B | 40.68B |
| Total Liabilities | 123.97B | 0.00 | 120.05B | 94.33B | 78.96B | 73.15B |
| Stockholders Equity | 90.93B | 94.80B | 82.12B | 69.35B | 61.97B | 56.23B |
Cash Flow | ||||||
| Free Cash Flow | 6.19B | 0.00 | 2.16B | 7.83B | 2.49B | 9.71B |
| Operating Cash Flow | 13.25B | 0.00 | 19.29B | 19.20B | 13.77B | 16.28B |
| Investing Cash Flow | -10.70B | 0.00 | -34.77B | -15.37B | -8.71B | -8.47B |
| Financing Cash Flow | -3.48B | 0.00 | 16.21B | -3.11B | -6.33B | -7.93B |
Apollo Hospitals Enterprise Limited Technical Analysis
Positive
7081.40
Price Trends
7666.73
Positive
7459.80
Positive
7505.61
Positive
Market Momentum
129.80
Negative
63.97
Neutral
58.51
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:APOLLOHOSP, the sentiment is Positive. The current price of 7081.4 is below the 20-day moving average (MA) of 7885.93, below the 50-day MA of 7666.73, and below the 200-day MA of 7505.61, indicating a bullish trend. The MACD of 129.80 indicates Negative momentum. The RSI at 63.97 is Neutral, neither overbought nor oversold. The STOCH value of 58.51 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:APOLLOHOSP.
Apollo Hospitals Enterprise Limited Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹107.45B | 44.11 | ― | 0.21% | 23.64% | 29.96% | |
71 Outperform | ₹388.91B | 75.82 | ― | 0.24% | 25.81% | -0.76% | |
66 Neutral | ₹1.16T | 50.39 | ― | 0.27% | 14.52% | 37.54% | |
66 Neutral | ₹1.05T | 84.46 | ― | 0.14% | 24.44% | 40.69% | |
66 Neutral | ₹333.70B | 46.41 | ― | 0.04% | 19.44% | 15.55% | |
61 Neutral | ₹735.33B | 86.12 | ― | 0.11% | 15.99% | 24.81% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,098.65
1,131.98
16.25%
IN:FORTIS
Fortis Healthcare Ltd.
974.00
302.40
45.03%
IN:MAXHEALTH
Max Healthcare Institute Ltd
1,076.30
-64.08
-5.62%
IN:MEDANTA
Global Health Limited
1,241.20
60.28
5.10%
IN:METROPOLIS
Metropolis Healthcare Ltd.
518.25
105.15
25.45%
IN:NH
Narayana Hrudayalaya Ltd.
1,903.05
166.09
9.56%
Apollo Hospitals Enterprise Limited Corporate Events
Apollo Hospitals Confirms SEBI-Compliant Dematerialisation of Shares for December 2025 Quarter
Jan 16, 2026
Apollo Hospitals Enterprise Limited has reported that, for the quarter ended 31 December 2025, all equity share certificates submitted for dematerialisation were duly processed, verified, and either accepted or rejected and communicated to the dep...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.